Loading clinical trials...
Loading clinical trials...
Single Dose Preliminary Dose-ranging and Safety in Patients With COPD
Conditions
Interventions
single dose of 5 mcg
single dose of placebo
+4 more
Locations
1
Netherlands
1222.3.1 Atrium medisch centrum
Heerlen, Netherlands
Start Date
December 1, 2005
Primary Completion Date
November 1, 2006
Completion Date
November 1, 2006
Last Updated
June 30, 2014
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions